Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 14, 2022
Patent Application Number
16928663
Date Filed
July 14, 2020
Patent Citations
Patent Primary Examiner
Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
